Table 4.

Appraisal of the patient decision aid (n = 69)

	Mostly disagree (1 point)	Neutral (3 points)	Mostly agree (5 points)	Mean ± SD
Subjective impact of the PtDA
I learned a lot from the PtDA	11 %	17 %	71 %
The PtDA contained new information	7 %	23 %	70 %
The PtDA helped me to gain insight into my preferences, worries and questions	9 %	22 %	70 %
The PtDA helped me in making a decision about medication	11 %	18 %	70 %
The PtDA helped me in discussing my preferences, worries and questions with my rheumatologist	11 %	28 %	60 %
Total impact				3.8 ± 0.9
Perceived usefulness
The PtDA in general was useful	7 %	5 %	88 %
Reading the general information was useful	2 %	5 %	94 %
The specific information about DMARDs was useful	4 %	3 %	94 %
Comparing DMARDs was useful	4 %	8 %	89 %
Making notes in the digital notebook was useful	22 %	51 %	28 %
The exercises about preferences and worries were useful	11 %	29 %	59 %
The list of frequently asked questions was useful	12 %	32 %	56 %
Total usefulness				4.0 ± 0.7
Perceived ease of use
The website is easy to use	5 %	3 %	92 %
The information is easy to understand	2 %	6 %	92 %
The time the PtDA takes to finish is acceptable	5 %	5 %	90 %
The structure of the website is logical	10 %	11 %	79 %
Total ease of use				4.5 ± 0.8
Attractiveness
The colour of the website is pleasant	2 %	17 %	81 %
The font on the website is pleasant	4 %	9 %	87 %
Total attractiveness				4.4 ± 0.9
Attitude towards future use
I would use the PtDA again in the future	5 %	3 %	91 %
I would recommend the PtDA to others	2 %	7 %	89 %
Total attitude				4.6 ± 0.9
Overall grade regarding the quality of the PtDA (range 0–10)				7.7 ± 0.9

Percentages do not include missing cases. PtDA patient decision aid, DMARD disease modifying anti-rheumatic drug